SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (354)2/7/2006 1:09:05 AM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 447
 
Finally, common sense voice!

Ophthalmology Volume 113, Number 3, March 2006

…1.25 mg (Avastin) that is used clinically…

10 mg/Kg ~ 800 mg -? ~ 650 doses

Miljenko

PS: result indicate that REGN data of +4 weeks drug therapeutic effect may hold.